Status:
UNKNOWN
Oncostatin M in Ulcerative Colitis Patients
Lead Sponsor:
Beni-Suef University
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Ulcerative colitis (UC) is a refractory disease characterized by symptoms such as diarrhea, bloody stools, and abdominal pain with repeated relapses and remissions.
Detailed Description
Evaluation of UC activity is important, and endoscopic evaluations of mucosal inflammation can facilitate subsequent prognostication. On the basis of these considerations, achievement of mucosal heali...
Eligibility Criteria
Inclusion
- All patients aged \>18 years and \<80 years, of both gender who diagnosed to have UC and given the consent for participation in the study
Exclusion
- 1- Any patient with systemic inflammation as Bronchial asthma. 2- History of cancer or tumor. 3- Autoimmune disease such as rheumatoid arthritis and systemic lupus erythematous
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT05974332
Start Date
August 1 2023
End Date
March 1 2024
Last Update
August 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.